Yayıncı "European Respiratory Soc Journals Ltd" Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed için listeleme
Toplam kayıt 11, listelenen: 1-11
-
Assesment of palliative care in lung cancer in Turkey (ASPECT study)
(European Respiratory Soc Journals Ltd, 2015)[No Abstract Available] -
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD (Meeting Abstract)
(European Respiratory Soc Journals Ltd, 2015)[No Abstract Available] -
Evaluation Of Vitamin B12 and D, Folic Acid and Homocystein Levels In Stable COPD Patients
(European Respiratory Soc Journals Ltd, 2020)[No Abstract Available] -
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
(European Respiratory Soc Journals Ltd, 2021)[No Abstract Available] -
General characteristics and therapeutic options in lung cancer in Turkey
(European Respiratory Soc Journals Ltd, 2015)[No Abstract Available] -
Infliximab, an anti-tumor necrosis factor-alpha attenuates bleomyc-ininduced pulmonary fibrosis in rats
(European Respiratory Soc Journals Ltd, 2015)[No Abstract Available] -
Investigation of SARS-CoV-2 RNA on Particulate Matters: A multicentre study in Turkey
(European Respiratory Soc Journals Ltd, 2021)[No Abstract Available] -
Microorganisms isolated in COPD patients hospitalised for acute exacerbations and their clinical correlations
(European Respiratory Soc Journals Ltd, 2012)[No Abstract Available] -
Non-sleepy obstructive sleep apnoea: to treat or not to treat?
(European Respiratory Soc Journals Ltd, 2019)Non-sleepy obstructive sleep apnoea (OSA) is thought to have a prevalence of around 20-25% in industrialised countries. However, the question of whether it should be routinely treated or not is controversial. This review ... -
OSTEOPROTEGERIN PLASMA CONCENTRATIONS ARE CORRELATED WITH FORCED EXPIRATORY VOLUME AT 1 SECOND (FEV1) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
(European Respiratory Soc Journals Ltd, 2013)[No Abstract Available] -
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD (Meeting Abstract)
(European Respiratory Soc Journals Ltd, 2015)[No Abstract Available]